Tessari Eben bought KNSA
September 29, 2025 · Form 4 insider transaction
Tessari Eben bought 42,000 shares of Kiniksa Pharmaceuticals International, plc at $17.92 per share, a transaction worth $752.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
42,000
Price
$17.92
Total value
$752.6K
InsiderTessari Eben
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateSeptember 29, 2025
Filing dateOctober 1, 2025
Shares owned after76,552
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 29, 2024.